Close Menu

NEW YORK (GenomeWeb) – Interpace Diagnostics reported today that its first quarter revenues rose 15 percent year over year.

For the quarter ended March 31, the molecular diagnostics firm reported revenues of $3.5 million compared to $3.0 million the year before.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.